EXOSC7
Basic information
Region (hg38): 3:44975241-45036066
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 0 | 0 |
Variants in EXOSC7
This is a list of pathogenic ClinVar variants found in the EXOSC7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-44976281-G-T | not specified | Uncertain significance (May 30, 2023) | ||
3-44976299-G-C | not specified | Uncertain significance (Sep 19, 2023) | ||
3-44989149-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
3-44989150-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
3-44989180-G-A | not specified | Uncertain significance (Feb 14, 2024) | ||
3-44989188-G-A | not specified | Uncertain significance (May 17, 2023) | ||
3-44989227-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
3-44989593-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
3-44997098-C-T | not specified | Uncertain significance (Mar 26, 2024) | ||
3-44997163-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
3-44997184-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
3-44997196-A-C | not specified | Uncertain significance (Jun 16, 2023) | ||
3-45001542-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
3-45005319-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
3-45005354-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
3-45005371-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
3-45007433-A-G | not specified | Uncertain significance (Aug 26, 2022) | ||
3-45007541-G-C | not specified | Uncertain significance (Mar 12, 2024) | ||
3-45007567-A-G | not specified | Uncertain significance (Aug 13, 2021) | ||
3-45007567-A-T | not specified | Uncertain significance (Dec 18, 2023) | ||
3-45011299-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
3-45026394-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
3-45026426-G-A | not specified | Uncertain significance (Sep 29, 2022) | ||
3-45035536-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
3-45035684-G-C | not specified | Uncertain significance (Sep 27, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXOSC7 | protein_coding | protein_coding | ENST00000265564 | 8 | 60826 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000104 | 0.812 | 125683 | 0 | 65 | 125748 | 0.000258 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.237 | 175 | 166 | 1.05 | 0.00000913 | 1880 |
Missense in Polyphen | 41 | 41.578 | 0.98609 | 455 | ||
Synonymous | 1.43 | 51 | 65.8 | 0.775 | 0.00000380 | 569 |
Loss of Function | 1.30 | 10 | 15.5 | 0.644 | 9.05e-7 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000556 | 0.000551 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000352 | 0.000352 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.;
- Pathway
- RNA degradation - Homo sapiens (human);Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.269
Intolerance Scores
- loftool
- 0.827
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.92
Haploinsufficiency Scores
- pHI
- 0.635
- hipred
- Y
- hipred_score
- 0.713
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.958
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Exosc7
- Phenotype
Gene ontology
- Biological process
- exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;RNA catabolic process;rRNA catabolic process;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U1 snRNA 3'-end processing;U4 snRNA 3'-end processing;U5 snRNA 3'-end processing;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;nuclear mRNA surveillance;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear polyadenylation-dependent mRNA catabolic process
- Cellular component
- nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleoplasm;nucleolus;cytosol
- Molecular function
- 3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding;AU-rich element binding